QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
3 Stocks in Focus That Recently Declared Dividend Hikes Amid High Inflation
Qiagen (QGEN) Securities Fraud Investigation - Levi & Korsinsky
QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V. on Behalf of Qiagen Stockholders and Encourages Investors to Contact the Firm
QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN
QGEN SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Levi & Korsinsky Announces Investigation of Securities Claims Against Qiagen N.V. (QGEN)
QGEN Investor Alert: Levi & Korsinsky Investigates Qiagen (QGEN) for Potential Securities Fraud
Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
QIAGEN N.V. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
Deciphering Qiagen (QGEN) International Revenue Trends
Lost Money on Qiagen N.V. (QGEN)? Contact Levi & Korsinsky to Protect Your Rights
Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing Transcript
QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
Qiagen (QGEN) Q1 Earnings and Revenues Lag Estimates
Qiagen (QGEN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Levi & Korsinsky Investigates Qiagen N.V. (QGEN) Over Potential Securities Fraud Allegations
QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm
QIAGEN Reports Full Results for Q1 2026
Qiagen Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Qiagen N.V. (QGEN)
Ongoing Investigation into Qiagen N.V. (QGEN): Contact Levi & Korsinsky About Potential Fraud
Qiagen N.V. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Qiagen N.V. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Qiagen N.V. (QGEN) Q1 2026 Earnings Call Transcript
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
Qiagen N.V. (NYSE:QGEN) Given Average Rating of “Hold” by Brokerages
Parse Biosciences, a QIAGEN Company, Launches FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis
Allspring Global Investments Holdings LLC Boosts Position in Qiagen N.V. $QGEN
Qiagen (NYSE:QGEN) Hits New 1-Year Low – Here’s What Happened
Qiagen (NYSE:QGEN) Sets New 12-Month Low – Should You Sell?
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
Bridgefront Capital LLC Takes Position in Qiagen N.V. $QGEN
Capital International Investors Boosts Holdings in Qiagen N.V. $QGEN
Capital Group Private Client Services Inc. Reduces Stock Position in Qiagen N.V. $QGEN
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
Qiagen N.V. (QGEN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Qiagen N.V. (NYSE:QGEN) Given Average Recommendation of “Hold” by Analysts
Qiagen N.V. (QGEN) Presents at Leerink Global Healthcare Conference 2026 Transcript
Why Is Qiagen (QGEN) Down 9.4% Since Last Earnings Report?
Qiagen N.V. (QGEN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Stock Traders Purchase High Volume of Qiagen Put Options (NYSE:QGEN)